NWSA
80
18
FCX
59
2
AVB
65
-2
TXT
55
2
MAC
65
-3
HAS
37
3
AON
56
-2
GME
65
-5
CMCSA
50
2
KLAC
57
4
BXP
55
-4
MRK
35
-5
AA
61
5
WEC
55
-3
MTCH
55
2
UNP
56
-3
PHM
64
-2
APA
30
3
EIX
77
-3
SCHW
65
-2
NWSA
80
18
FCX
59
2
AVB
65
-2
TXT
55
2
MAC
65
-3
HAS
37
3
AON
56
-2
GME
65
-5
CMCSA
50
2
KLAC
57
4
BXP
55
-4
MRK
35
-5
AA
61
5
WEC
55
-3
MTCH
55
2
UNP
56
-3
PHM
64
-2
APA
30
3
EIX
77
-3
SCHW
65
-2
Financhill
Back

Cryo-Cell International 10K Form

Buy
78

CCEL
Cryo-Cell International

Last Price:
8.57
Seasonality Move:
4.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CCEL News And Ratings

See the #1 stock for the next 7 days that we like better than CCEL

CCEL Financial Statistics

Sales & Book Value

Annual Sales: $31.34M
Cash Flow: $2.12M
Price / Cash Flow: 40.7
Annual Sales: $-1.19
Price / Book: 0

Profitability

EPS (TTM): -1.07300
Net Income (TTM): $-8.93M
Gross Margin: $22.9M
Return on Equity: 0%
Return on Assets: -14.03%

Cryo-Cell International Earnings Forecast

Key Cryo-Cell International Financial Ratios

  • The Gross Profit Margin over the past 28 years for CCEL is 73.07%.
  • The Selling, General & Administrative Expenses for CCEL have been equal to 54.61% of Gross Profit Margin.
  • The Research & Development expenses have been 3.74% of Revenue.
  • The Interest Expense is -12.99% of Operating Income.
  • The Net Earning history of CCEL is -30.38% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Cryo-Cell International Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: CCEL
Website: cryo-cell.com

Debt

Debt-to-Equity Ratio: -1.12
Current Ratio: 0.61
Quick Ratio: 0.52

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 72.25

CCEL Technical Analysis vs Fundamental Analysis

Buy
78
Cryo-Cell International (CCEL) is a Buy

Is Cryo-Cell International a Buy or a Sell?